SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on January 23, 2015. The report details the consummation of a third closing under a Unit Purchase Agreement dated December 19, 2014, involving the sale of unregistered equity securities to accredited investors.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial data disclosed relates to the capital raise:
- Total Consideration Received: $1,071,000
- Shares Issued: 428,400 shares of Common Stock
- Warrants Issued: 428,400 "A" Warrants (exercise price $2.50) and 214,200 "B" Warrants (exercise price $3.75)
- Units Sold: 10.71 units
Material Changes
The primary material change is the increase in outstanding equity and potential dilution resulting from the third closing. This transaction follows two prior closings on December 19, 2014, and December 30, 2014, which raised an aggregate of $512,100 for 204,840 shares and associated warrants. The securities were sold under Section 4(a)(2) and Regulation D exemptions.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, or discussion of operational risks. It notes that the summaries of the Purchase Agreement, Investor Warrants, and Registration Rights Agreement are not complete and are qualified by reference to the full text of the agreements, which will be filed as exhibits to the Form 10-K for the fiscal year ended December 31, 2014.
Investor Verification Checklist
- Verify the total aggregate capital raised across all three closings ($1,583,100).
- Confirm the total number of shares and warrants outstanding post-transaction.
- Review the full text of the Unit Purchase Agreement and Registration Rights Agreement in the upcoming Form 10-K for specific terms and restrictions.
- Check the company's current cash position to understand the immediate impact of the $1,071,000 infusion.